Abstract
SummaryBackgroundEngland's COVID-19 roadmap out of lockdown policy set out the timeline and conditions for the stepwise lifting of non-pharmaceutical interventions (NPIs) as vaccination roll-out continued, with step one starting on March 8, 2021. In this study, we assess the roadmap, the impact of the delta (B.1.617.2) variant of SARS-CoV-2, and potential future epidemic trajectories.MethodsThis mathematical modelling study was done to assess the UK Government's four-step process to easing lockdown restrictions in England, UK. We extended a previously described model of SARS-CoV-2 transmission to incorporate vaccination and multi-strain dynamics to explicitly capture the emergence of the delta variant. We calibrated the model to English surveillance data, including hospital admissions, hospital occupancy, seroprevalence data, and population-level PCR testing data using a Bayesian evidence synthesis framework, then modelled the potential trajectory of the epidemic for a range of different schedules for relaxing NPIs. We estimated the resulting number of daily infections and hospital admissions, and daily and cumulative deaths. Three scenarios spanning a range of optimistic to pessimistic vaccine effectiveness, waning natural immunity, and cross-protection from previous infections were investigated. We also considered three levels of mixing after the lifting of restrictions.FindingsThe roadmap policy was successful in offsetting the increased transmission resulting from lifting NPIs starting on March 8, 2021, with increasing population immunity through vaccination. However, because of the emergence of the delta variant, with an estimated transmission advantage of 76% (95% credible interval [95% CrI] 69–83) over alpha, fully lifting NPIs on June 21, 2021, as originally planned might have led to 3900 (95% CrI 1500–5700) peak daily hospital admissions under our central parameter scenario. Delaying until July 19, 2021, reduced peak hospital admissions by three fold to 1400 (95% CrI 700–1700) per day. There was substantial uncertainty in the epidemic trajectory, with particular sensitivity to the transmissibility of delta, level of mixing, and estimates of vaccine effectiveness.InterpretationOur findings show that the risk of a large wave of COVID-19 hospital admissions resulting from lifting NPIs can be substantially mitigated if the timing of NPI relaxation is carefully balanced against vaccination coverage. However, with the delta variant, it might not be possible to fully lift NPIs without a third wave of hospital admissions and deaths, even if vaccination coverage is high. Variants of concern, their transmissibility, vaccine uptake, and vaccine effectiveness must be carefully monitored as countries relax pandemic control measures.FundingNational Institute for Health Research, UK Medical Research Council, Wellcome Trust, and UK Foreign, Commonwealth and Development Office.
Highlights
Interpretation Our findings show that the risk of a large wave of COVID-19 hospital admissions resulting from lifting non-pharmaceutical interventions (NPIs) can be substantially mitigated if the timing of NPI relaxation is carefully balanced against vaccination coverage
Despite the UK being the first country to start nationwide vaccination campaigns,[1] the emergence of the alpha (B.1.1.7) variant of concern drove the severe second wave over the 2020–21 winter leading to a third lockdown in England from Jan 5, 2021.2 Informed by mathematical modelling, the UK Government published a roadmap out of lockdown policy for England, setting out the conditions for and expected timeline of a stepwise lifting of non-pharmaceutical interventions (NPIs).[3]
We show the benefits of maintaining non-pharmaceutical interventions while vaccine coverage continues to increase and capture key uncertainties in the epidemic trajectory after NPIs are lifted
Summary
Despite the UK being the first country to start nationwide vaccination campaigns,[1] the emergence of the alpha (B.1.1.7) variant of concern drove the severe second wave over the 2020–21 winter leading to a third lockdown in England from Jan 5, 2021.2 Informed by mathematical modelling, the UK Government published a roadmap out of lockdown policy for England, setting out the conditions for and expected timeline of a stepwise lifting of non-pharmaceutical interventions (NPIs).[3]. By July 19, 87·5% of the adult population in England had received at least one dose of vaccine, and 68·2% had received two doses.[1] The impact of each roadmap step was assessed in real time before further interventions were lifted, against the Government’s four tests as follows: continued success of the vaccine programme; evidence of the effectiveness of vaccines against hospitalisation; no risk of overwhelming the National Health Service (NHS); and new variants of concern do not change the risk assessment.[3]. None explicitly analysed real-world evidence, balancing lifting of interventions, vaccination, and emergence of the delta variant
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
